Kolexia
Supiot Stephane Oncologie radiothérapie
Supiot Stephane
Oncologie radiothérapie
Institut de cancérologie de l'Ouest
Saint-Herblain, France
394 Activités
346 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Métastase tumorale Récidive tumorale locale Adénocarcinome Tumeurs du cerveau Lésions radiques Épendymome Tumeurs du sein Carcinomes

Collaborateurs

Voir plus
Sargos Paul
Sargos Paul
Institut Bergonié, Bordeaux, France
Crehange Gilles
Crehange Gilles
Clcc Institut Curie, Paris, France
Latorzeff Igor
Latorzeff Igor
Hôpital Rangueil, Toulouse, France
De Crevoisier Renaud
De Crevoisier Renaud
Centre Eugène Marquis, Rennes, France

Industries

Voir plus
Janssen
84 collaboration(s)
Dernière en 2023
Bayer
34 collaboration(s)
Dernière en 2023
Astellas
30 collaboration(s)
Dernière en 2023
Ipsen
27 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
In Regard to Trotter et al.
Advances in radiation oncology   15 février 2024
TEMPOS: Erectile Dysfunction in Good Prognosis Prostate Cancer: a Phase III Medico-economic Study Comparing Brachytherapy to Stereotactic Body Radiotherapy
Essai Clinique (Centre Eugène Marquis)   06 février 2024
A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility.
BMC cancer   25 janvier 2024
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   23 décembre 2023
How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists.
Clinical and translational radiation oncology   18 décembre 2023
STEREO-OS: Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
Essai Clinique (Unicancer)   11 décembre 2023
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clinical and translational radiation oncology   17 novembre 2023
Bladder-ART: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Essai Clinique (Unicancer)   09 novembre 2023
PEACE1: A Prospective Randomised Phase III Study Of Androgen Deprivation Therapy With Or Without Docetaxel With Or Without Local Radiotherapy With Or Without Abiraterone Acetate And Prednisone In Patients With Metastatic Hormone-Naïve Prostate Cancer
Essai Clinique (Ipsen)   07 novembre 2023
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies.
European urology   07 novembre 2023